QIXTOLO Trademark

Trademark Overview


On Wednesday, April 7, 2021, a trademark application was filed for QIXTOLO with the United States Patent and Trademark Office. The USPTO has given the QIXTOLO trademark a serial number of 90628953. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, October 16, 2023. This trademark is owned by Eli Lilly and Company. The QIXTOLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
qixtolo

General Information


Serial Number90628953
Word MarkQIXTOLO
Filing DateWednesday, April 7, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, October 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 28, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Wednesday, October 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 16, 2023SOU EXTENSION 4 GRANTED
Monday, October 16, 2023SOU EXTENSION 4 FILED
Monday, October 16, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023SOU EXTENSION 3 GRANTED
Monday, April 17, 2023SOU EXTENSION 3 FILED
Monday, April 17, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 18, 2022SOU EXTENSION 2 GRANTED
Tuesday, October 18, 2022SOU EXTENSION 2 FILED
Tuesday, October 18, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU EXTENSION 1 GRANTED
Tuesday, April 19, 2022SOU EXTENSION 1 FILED
Monday, April 25, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 19, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 25, 2021ASSIGNED TO EXAMINER
Wednesday, July 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 10, 2021NEW APPLICATION ENTERED